Zobrazeno 1 - 4
of 4
pro vyhledávání: '"R F, Enikeev"'
Publikováno v:
Сибирский онкологический журнал, Vol 18, Iss 5, Pp 80-85 (2019)
The incidence of neuroendocrine tumors has significantly increased over the last years.The purpose of the study was to analyze treatment outcomes in patients with pancreatic endocrine tumors (PETs) with regard to histopathologic diagnosis.Material an
Externí odkaz:
https://doaj.org/article/9b57624ca7dd469d98fd9548cbef2dda
Autor:
E V Artamonova, E I Kovalenko, A V Snegovoy, A A Aksarin, T A Anciferova, A V Belonogov, E V Bilan, S N Bilenko, I M Varvus, E A Gorkovenko, R F Enikeev, A M Ermolaeva, L V Kramskaya, I B Kononenko, A P Pechenyy, S Z Safina, T V Chupriyanova, G G Chuhua, A I Shemyakina, E V Shikina
Publikováno v:
Современная онкология, Vol 20, Iss 3, Pp 19-25 (2018)
Background and aims. There is no data on olaparib efficacy and safety in Russian routine clinical practice. Methods. We analysed the 30 consecutive patients who received maintenance olaparib treatment for platinum-sensitive relapse (PSR) of ovarian o
Externí odkaz:
https://doaj.org/article/dd31107e3e054b2f8a0745e52e2e870d
Autor:
O. I. Brovkina, M. G. Gordiev, R. F. Enikeev, M. O. Druzhkov, L. Kh. Shigapova, E. I. Shagimardanova, O. А. Gusev, V. V. Kosiy, D. S. Khodyrev, A. G. Kedrova, R. Sh. Khasanov, A. G. Nikitin
Publikováno v:
Опухоли женской репродуктивной системы, Vol 13, Iss 2, Pp 61-67 (2017)
Introduction. Development of hereditary ovarian cancer (OC) and breast cancer (BC) is caused by genetic abnormalities in the DNA reparation system consisting of more than 100 genes. However, currently in the majority of medical centers in Russia, dia
Externí odkaz:
https://doaj.org/article/d351bc03447e4ae2a36b096e9306e9f1
Autor:
O I, Brovkina, M G, Gordiev, A N, Toropovskiy, D S, Khodyrev, R F, Enikeev, O A, Gusev, L H, Shigapova, A G, Nikitin
Publikováno v:
Biomeditsinskaya Khimiya. 62:638-644
The presence of activating mutations in the EGFR gene influences cell proliferation, angiogenesis, and increases metastatic ability; it has a significant impact on the choice of medical therapy of non-small cell lung cancer (NSCLC). The use of target